Additionally, nigericin may enhance its therapeutic efficacy against AML by potentially lowering intracellular pH and inducing apoptosis through a mechanism similar to that of Sodium-Hydrogen Exchanger 1 (NHE1) inhibitors [39]. The gene discussed is SLC9A1; the disease is acute myeloid leukemia.